Dasiglucagon for the Treatment of Insulin-induced Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Meta-analysis.

Shampa Maji Rashmi Ranjan Mohanty Rituparna Maiti

Published in: Balkan medical journal (2023)

Dasiglucagon is safer and more effective than placebo or oral glucose for insulin-induced hypoglycemia in T1DM patients; however, it is not superior to conventional glucagon.

Keyphrases

type diabetes
glycemic control
high glucose
end stage renal disease
diabetic rats
ejection fraction
chronic kidney disease
blood glucose
drug induced
prognostic factors
randomized controlled trial
clinical trial
endothelial cells
skeletal muscle
open label
stress induced
replacement therapy